Assenagon Asset Management S.A. Care Dx, Inc. Transaction History
Assenagon Asset Management S.A.
- $37.1 Billion
- Q1 2024
A detailed history of Assenagon Asset Management S.A. transactions in Care Dx, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 356,573 shares of CDNA stock, worth $4.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
356,573
Previous 576,347
38.13%
Holding current value
$4.64 Million
Previous $6.92 Million
45.4%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$76.3 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$70.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$55.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$54.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$51.2 Million0.65% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $695M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...